Case Report
Accepted on 28 Mar 2025
Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
Frontiers in Hematology
doi 10.3389/frhem.2025.1547209
Volumes
127 Publications
Volume 4 - 2025
Review
Accepted on 26 Mar 2025
Metabolic Reprogramming of Fetal Hematopoietic Stem and Progenitor Cells by Maternal Obesity
Frontiers in Hematology
doi 10.3389/frhem.2025.1575143
Clinical Trial
Accepted on 21 Mar 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 568 views
Original Research
Published on 21 Mar 2025
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
- 189 views
Brief Research Report
Accepted on 18 Mar 2025
Assessing Maternal and Perinatal Complication Incidence in Pregnant Patients with Sickle Cell Disease: A Retrospective Analysis of Transfusion Therapy at a Tertiary Care Hospital
Frontiers in Hematology
doi 10.3389/frhem.2025.1549241
Original Research
Accepted on 17 Mar 2025
Anemia and its predictors among neonates at Wachemo University Teaching Hospital, Central Ethiopia. A Facility based cross-sectional study
Frontiers in Hematology
doi 10.3389/frhem.2025.1550664
Original Research
Published on 17 Mar 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 420 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 485 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 269 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 517 views
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 291 views
Mini Review
Published on 26 Feb 2025
The role of glucocorticoids in erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
- 365 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 364 views
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 264 views
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 512 views